Start › Szpiczak mnogi › New Jersey › Edison
Badania kliniczne dla Szpiczak mnogi w mieście Edison, NJ
22 badań dla Szpiczak mnogi szuka uczestników w ośrodkach w mieście Edison i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RekrutacjaFaza 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekrutacjaFaza 3
- Astera Cancer Care, East Brunswick · 6 mi dalej
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekrutacjaFaza 3
- Astera Cancer Care, East Brunswick · 6 mi dalej
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RekrutacjaFaza 3
- MSK Basking Ridge, Basking Ridge · 15 mi dalej
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RekrutacjaFaza 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi dalej
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RekrutacjaFaza 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi dalej
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekrutacjaFaza 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi dalej
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RekrutacjaFaza 3
- MSK Basking Ridge, Basking Ridge · 15 mi dalej
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RekrutacjaFaza 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekrutacjaFaza 3
- Research Site, East Brunswick · 6 mi dalej
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RekrutacjaBadanie obserwacyjne
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RekrutacjaFaza 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RekrutacjaFaza 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RekrutacjaFaza 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
RekrutacjaWczesna faza 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi dalej
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi dalej
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
RekrutacjaFaza 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi dalej
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekrutacjaFaza 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi dalej
A Dietary Study for People With Multiple Myeloma
Rekrutacja
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekrutacjaFaza 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi dalej
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RekrutacjaFaza 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi dalej
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi dalej
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Rekrutacja
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi dalej
Badania dla Szpiczak mnogi w innych miastach
- New York City, NY60 badań
- Boston, MA42 badań
- Atlanta, GA41 badań
- Houston, TX38 badań
- Durham, NC37 badań
- Nashville, TN32 badań
- Denver, CO27 badań
- Rochester, MN24 badań
- St. Louis, MO24 badań
- Columbus, OH24 badań
- Baldwin Park, CA23 badań
- Chicago, IL22 badań
Inne badania w mieście Edison
- Rak piersi68 badań
- Niedrobnokomórkowy rak płuca47 badań
- Nowotwory (wszystkie typy)33 badań
- Rak prostaty29 badań
- Rak jelita grubego i odbytnicy23 badań
- Rak płuc23 badań
- Rak pęcherza moczowego21 badań
- Nowotwór przerzutowy20 badań
- Rak jajnika20 badań
- Ostra białaczka szpikowa20 badań
- Rak endometrium19 badań
- Rak urotelialny (przejściowokomórkowy)18 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.